Perkembangan Bioteknologi Masa Kini
Abstract
The modern products of biotechnology are, vaccine, interferon, interleukin, monoclonal antibody, new rice varieties, antibiotics, biological pesticides such as bacteria Bacillus thuringiensis which are active against specific insect species and their application through transgenic plants. There is a great difference in the products if compared with those of the conventional biotechnology, such as soy sauce, fish sauce, yoghurt, ethanol and tempe. Nowadays HIV/AIDS, pneumonia virus SARS (severe acute respiratory syndrome), genetic disorder, cloning, biological weapon such as anthrax from Bacillus anthraxis, are the kinds of several diseases, discoveries and conditions which look for development and clarification through biotechnology. It was shown in this paper some new biotechnology products, technology scope closely related to biotechnology and also the comparation of national priorities and strategy for developing of biotechnology in developed and developing countries.
References
2. Witarto AB, Kebijakan Bioteknologi Jepang : Upaya Pemerintah Menjadikan Bioteknologi Menjadi Industri Andalan Masa Depan, Proceedings of Seminar on Science Policy, ISTECS Chapter Japan, 2000.
3. Mugabe J, Biotechnology in Developing Countries and Countries with Economies Transition : Strategic Capacity Building Considerations, Background Paper Prepared for the United Nations Conference on Trade and Development (UNCTAD). Geneva. Switzerland, April 5, 2000.
4. Jembere K and Belete W. Towards a National Biotechnology Policy in Ethiopia. Paper prepared for Biotechnology and Public Policy Training Course, Organized by The African Centre for Technology Studies (ACTS), Nairobi. Kenya, 1999.
5. Lee, Kongres National Innovation System of Korea, Presented at S&T and R&D Management Training Program, STEPI., 2001.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.